News

$Rezolute(RZLT.US)$ The European Medicines Agency Has Granted Priority Medicines (PRIME) Eligibility To Rezolute's Rz358 For The Treatment Of Congenital Hyperinsulinism

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate